Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-27

Clinical Trial Update: Milk Thistle Clinical Trial in Pediatric NAFLD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating milk thistle in pediatric non-alcoholic fatty liver disease is currently recruiting, sponsored by University Hospitals Cleve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milk Thistle (silymarin)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Status: RECRUITING